Trial intelligence / Profile preview

Febuxostat vs allopurinol in gout-related hyperuricemia (phase II, China)

CTR20130135Phase 2Active

Start
Jun 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of febuxostat in hyperuricemia, gout. Started Jun 2013; status: active.

02

Drugs

febuxostat
03

Conditions

hyperuricemiagout

Beyond the preview

Go deeper on CTR20130135.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130135.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call